Clinical trial
Temozolomide in Treating Patients With Mycosis Fungoides or Sezary Syndrome
NCT00004106 · Northwestern University, Other · Terminated
Key facts
| NCT number | NCT00004106 |
|---|---|
| Title | Temozolomide in Treating Patients With Mycosis Fungoides or Sezary Syndrome |
| Official title | Phase II Trial of Temozolomide for the Treatment of Mycosis Fungoides and the Sezary Syndrome |
| Lead sponsor | Northwestern University, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Drug |
| Interventions | temozolomide |
| Enrollment | 29 |
| Start date | May 1, 1998 |
| Primary completion | Apr 1, 2006 |
| Completion | Apr 1, 2006 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 6, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: